Abstract Body

Background: The HIV/AIDS pandemic remains an important threat to global health. Although cART (combination antiretroviral therapy) induces a rapid decline in plasma HIV-1 RNA, persistence of latent forms of HIV-1 displays the major hurdle on the way to eradicating the infection. Recent data indicate that at least a subset of patients harbor a sufficiently suppressed viral reservoir which is not able to fuel viral rebound upon therapy discontinuation. These so-called functionally cured patients provide new hope for an HIV cure by the elimination of replication-competent HIV-1 reservoirs.
Based on our experience from the analysis of more than 1 million lentivirus vector insertion sites (IS) we hypothesized that significant portions of inserted provirus in patients might be non-randomly distributed and/or clonally stable and/or within illegitimate, non-canonical LTR boundaries.

Methods: To study wtHIV IS in human patients, we determined genomic/proviral flanking regions in untreated (n=39) and cART treated (n=32, including amongst others an integrase inhibitor) patient cohorts using linear amplification-mediated PCR (LAM-PCR) in a longitudinal analysis. The clonal inventory of infected cells was obtained using next-generation sequencing combined with a novel double barcoding system in combination with innovative bioinformatic analysis. Integrome analysis was done to quantify chromosomal distribution of IS, illegitimate non-integrase mediated HIV-1 integration and clonal persistence indicative of virus-host genome interactions.

Results: Our data describe for the first time the existence of LTR micro-deletions in wtHIV infected CD4 positive patient cells. To generate the IS profile we identified more than 2500 integration sites from wtHIV-1 infected patient samples pre and post therapy and identified common IS.
To monitor longitudinal IS distribution, we performed high-throughput IS analysis at up to eight different time points up to 330 days after therapy. Identical IS were found at multiple time points proving the existence of a persisting reservoir of dividing infected cells in patients.

Conclusions: This finding is in line with recent reports where the authors postulate that the location of HIV ISs can promote the expansion and persistence on HIV infected cells (Maldarelli et al. 2014, Wagner et al. 2014). In addition our data proof LTR micro-deletions in wtHIV infected patient cells and focus on HIV integration in humans on a large cohort of treated and untreated patient samples.